Summary: Insulin detemir is a long-acting, neutral, and soluble insulin analogue with a lower within-subject variability of fasting plasma glucose levels than isophane insulin human (NPH insulin ...

The FDA approved its short-acting insulin, Fiasp (insulin aspart injection ... safe and effective alternatives to brand name drugs approved through the agency’s abbreviated pathways.” ...

The global rapid acting insulin market was valued at $7,100 million in 2019, and is projected to reach $8,925 million by 2027 at a CAGR of 4.1% from 2020 to 2027. The growth of the global rapid acting ...

“But it’s not fully understood.” People with Type 1 or 1.5 diabetes rely on both short acting and long acting insulin. Short acting insulin manages their blood sugar after eating and long ...

In 29% of patients, home oral glucose lowering agents were held during hospitalization and scheduled insulin was not initiated. Although the reasons for holding home medications were not collected, ...

The quickest way to lower your blood sugar is to take fast-acting insulin. However ... some exercises — particularly short bursts of strenuous activity — can briefly increase blood sugar ...

Some diabetes patients in the U.S. have this year pushed back against the company's decision to stop selling its long-acting insulin Levemir, which is an analogue insulin. They say the move has ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

Short Wave New discoveries, everyday mysteries, and the science behind the headlines — in just under 15 minutes. It's science for everyone, using a lot of creativity and a little humor.

Adding more activity into your day by taking the stairs instead of the elevator, parking your car further from the door, or taking short walks at lunch or breaks can make a difference in your health ...